WHO endorses “zero” transmission risk for people with HIV with an undetectable viral load
1 August 2023. Related: Conference reports, Treatment strategies, HIV prevention and transmission.
2023
Viral load level when suppressed <1000 predicts future rebound: 3-monthly monitoring required
1 August 2023. Related: Conference reports, HIV prevention and transmission.
ART-associated hypertension can be successfully treated in African settings
1 August 2023. Related: Conference reports, Side effects, Coinfections and complications.
REPRIEVE study: statin benefits people living with HIV at low to moderate CVD risk
1 August 2023. Related: Conference reports, Coinfections and complications.
Geneva patient and other HIV cure research at IAS 2023
1 August 2023. Related: Conference reports, Cure-related research.
Guide to other HIV cure-related research at IAS 2023
1 August 2023. Related: Conference reports.
Rapporteur summaries: track B clinical science
1 August 2023. Related: Conference reports, Antiretrovirals.
Early press conference: cure, gay circumcision, PrEP choices, mpox, and COVID-19
1 August 2023. Related: Conference reports, mpox (monkeypox), HIV prevention and transmission, Cure-related research, COVID-19: HIV and COVID-19 coinfection, COVID-19.
High rates of occult HBV in Botswana: risks from relying on HBsAg screening
1 August 2023. Related: Conference reports, Hepatitis coinfection.
Anal cancer: 1 in 5 risk of missing precancerous lesions if only HSIL are biopsied
1 August 2023. Related: Conference reports, Cancer and HIV.
29th BHIVA Annual Conference 2023 (BHIVA 2023) – final reports
1 August 2023. Related: Conference reports.
No vertical HIV transmissions in the UK from women eligible for supported breastfeeding
1 August 2023. Related: Conference reports, Pregnancy, Paediatric care.
Adverse birth outcomes with diabetes and hypertensive disorders in pregnancy
1 August 2023. Related: Conference reports, Pregnancy.
CAB-LA receives positive opinion for EU approval as PrEP
1 August 2023. Related: Antiretrovirals, HIV prevention and transmission.
New UK vaccine schedule for HPV depends on HIV status
1 August 2023. Related: Guidelines, Coinfections and complications, Cancer and HIV.
UK shingles vaccine: changes from 1 September 2023
1 August 2023. Related: Guidelines, Coinfections and complications.
New guidelines on cognitive impairment in people living with HIV
1 August 2023. Related: Guidelines, Coinfections and complications.
PrEP for women and PrEP: new translations (June 2023)
1 August 2023. Related: HIV prevention and transmission.
HTB: no. 7/8 (July/August 2023) PDF download
1 August 2023. Related: PDFs.
Featured HTB May/June 2023: HIV and implementation science
1 June 2023. Related: Editorial.
Non technical HTB news: 12 stories from May/June issue
1 June 2023. Related: Editorial.
New i-Base pocket leaflets (May 2023)
1 June 2023. Related: Editorial.
BHIVA Annual Conference 2023 (BHIVA 2023)
1 June 2023. Related: Conference reports.
UK cascade data cautions UNAIDS 95:95:95 targets: re-engaging people in care
1 June 2023. Related: Conference reports, Treatment strategies, Treatment advocacy.
Overview of weight gain, integrase inhibitors and ART
1 June 2023. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Selected webcasts from BHIVA 2023
1 June 2023. Related: Conference reports, Treatment strategies, Side effects, Lipodystrophy and metabolic complications.
30th CROI (CROI 2023): final reports
1 June 2023. Related: Conference reports.
Viral reservoir increases on long-term ART: new strategies for a cure
1 June 2023. Related: Conference reports, Cure-related research.
Microbiota biomarkers might predict risk of HSIL progression: succinyl-CoA and cobalamin
1 June 2023. Related: Conference reports, Cancer and HIV.
CROI overviews by BHIVA and IAS-USA
1 June 2023. Related: Conference reports.
BHIVA guidelines modify assessment of cardiovascular risk (2023)
1 June 2023. Related: Guidelines.
NHS England approves use of F/TAF as alternative PrEP
1 June 2023. Related: HIV prevention and transmission.
BHIVA guidelines on non-TB mycobacteria (NTM)
1 June 2023. Related: Guidelines, Coinfections and complications.
No benefit on HIV-associated neurocognitive impairment from CNS-penetrating ART
1 June 2023. Related: Coinfections and complications.
First successful liver transplant from living donor with HIV/HCV coinfection: surgical video online
1 June 2023. Related: Coinfections and complications, Hepatitis coinfection.
US studies report mpox vaccine efficacy from single- vs double-dose might only be 36% vs 66%
1 June 2023. Related: mpox (monkeypox).
Review of idiopathic lymphocytopenia
1 June 2023. Related: Coinfections and complications, Basic science and immunology.
ART increases life expectancy by 30 to 40 years: impact of CD4 count, sex and calendar year
1 June 2023. Related: Antiretrovirals, Treatment strategies, Ageing and life expectancy.
Tracking HIV A6 strain in Europe: implications for injectable CAB-LA for treatment or PrEP
1 June 2023. Related: Drug resistance.
Tenofovir reduces risk of COVID-19 in pre-vaccine studies
1 June 2023. Related: COVID-19: HIV and COVID-19 coinfection, COVID-19.
HTB: no. 5/6 (May/June 2023) PDF download
1 June 2023. Related: PDFs.
Long-term survivors & HIV cure research
21 April 2023. Related: On the web.
HTB: no. 4 (April 2023) PDF download
6 April 2023. Related: PDFs.
Featured HTB April 2023 (6 April 2023)
6 April 2023. Related: Editorial.
David Wojnarowicz: F**k You F*ggot F**ker – now online
6 April 2023. Related: Treatment advocacy, Book and film reviews, On the web.
30th CROI (CROI 2023): further reports
6 April 2023. Related: Conference reports.
IAS-USA update HIV drug resistance tables
6 April 2023. Related: Drug resistance.
Dapivirine ring safe in late pregnancy and during breastfeeding
6 April 2023. Related: Conference reports.
Implications of restrictions on reproductive rights for HIV care in the USA and beyond
6 April 2023. Related: Conference reports, Treatment access, Women's health, Pregnancy.
Generic versions of injectable PrEP could enable access to CAB-LA in low-income countries
6 April 2023. Related: Antiretrovirals, HIV prevention and transmission.
Statins reduce heart disease by 35% in the international HIV REPRIEVE study
6 April 2023. Related: Coinfections and complications.
Penile BOTOX injections improve blood flow and other outcomes in men with moderate to severe erectile dysfunction
6 April 2023. Related: Coinfections and complications.
UK data on efficacy of mpox vaccine: caution needed in observational analyses
6 April 2023. Related: mpox (monkeypox).
Updates on US mpox research: surveillance, testing, vaccines and research
6 April 2023. Related: mpox (monkeypox).
HIV cures 3, 4 and 5: Düsseldorf case published, City of Hope patient gives public interview, New York case published
6 April 2023. Related: Cure-related research.
Cases of mpox reinfection in HIV negative men on PrEP: atovaquone, mefloquine and molnupiravir as potential treatments
6 April 2023. Related: mpox (monkeypox).
Training webinar: 2nd HIV from A to Z
6 April 2023. Related: On the web, Future meetings.
30th Conference on Retroviruses and OIs (CROI 2023): first reports
10 March 2023. Related: Conference reports.
Featured HTB March 2023 (10 March 2023)
10 March 2023. Related: Editorial.
CROI 2023: Pipeline HIV drugs and formulations for treatment and PrEP
10 March 2023. Related: Conference reports, Antiretrovirals.
CROI 2023: Six-monthly ART – lenacapavir + dual bNAbs maintains undetectable viral load for 26 weeks after single doses
10 March 2023. Related: Conference reports, Antiretrovirals.
CROI 2023: Other lenacapavir studies – experienced and naive updates, the dosing window, HIV-2 and PrEP
10 March 2023. Related: Conference reports, Antiretrovirals.
CROI 2023: Similar PK profile for thigh vs gluteal CAB/RPV-LA injections: accidental intravenous injection
10 March 2023. Related: Conference reports, Antiretrovirals.
CROI 2023: Efficacy of N6LS monotherapy correlated with baseline factors
10 March 2023. Related: Conference reports, Antiretrovirals.
CROI 2023: CAB/RPV-LA levels are not reduced after switching from efavirenz
10 March 2023. Related: Conference reports, PK and drug interactions.